| Name | Methyl (1S,3S,7S,12R,15R,16S,17S,18R,20E)-12-(3,4-dihydroxyphenyl)-20-ethylidene-16,17,18-trihydroxy-9-oxo-2,4,10,13,19-pentaoxatricyclo[13.3.1.13,7]icos-5-ene-6-carboxylate (non-preferred name) |
|---|---|
| Synonyms |
Methyl (1S,3S,7S,12R,15R,16S,17S,18R,20E)-12-(3,4-dihydroxyphenyl)-20-ethylidene-16,17,18-trihydroxy-9-oxo-2,4,10,13,19-pentaoxatricyclo[13.3.1.1]icos-5-ene-6-carboxylate
2H-Pyran-4-acetic acid, 2-[[6-O-[(1R)-1-(3,4-dihydroxyphenyl)-2-hydroxyethyl]-β-D-glucopyranosyl]oxy]-3-ethylidene-3,4-dihydro-5-(methoxycbonyl)-, intramol. 4,2''-ester, (2S,3E,4S) |
| Description | Fraxamoside is a competitive xanthine oxidase inhibitor with an IC50 of 16.1 μM and a Ki of 0.9 μM[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 825.8±65.0 °C at 760 mmHg |
| Molecular Formula | C25H30O13 |
| Molecular Weight | 538.50 |
| Flash Point | 277.9±27.8 °C |
| Exact Mass | 538.168640 |
| PSA | 190.67000 |
| LogP | 1.26 |
| Vapour Pressure | 0.0±3.2 mmHg at 25°C |
| Index of Refraction | 1.614 |
| Hazard Codes | Xi |
|---|